Kazakhstan: veterinary medicine producer Antigen enters new markets
Twelve new animal vaccines have been developed by the research and production enterprise Antigen, an EBRD advisory client in Kazakhstan. Thanks to a project funded by the Kazakhstan government, the vaccines will be sold abroad. With the help of international advisers, the company was able to conform to the requirements of globally recognised Good Manufacturing…